子宫内膜癌的分子分类和新出现的靶向治疗

Ting-Tai Yen, M.D., Tian-Li Wang, Ph.D., Amanda N. Fader, M.D., Ie-Ming Shih, M.D., Ph.D., and Stéphanie Gaillard, M.D., Ph.D.

From the TeLinde Gynecologic Pathology Research Program, Department of Gynecology and Obstetrics (T.T.Y., T.L.W., I.M.S., S.G.); Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics (T.T.Y., A.N.F., S.G.); Department of Pathology (T.L.W.); and Department of Oncology (S.G.), Johns Hopkins University School of Medicine, Baltimore, Maryland.

Supported by Richard W. TeLinde endowment, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine and NIH/NCI grant, P50 CA228991-01.

The authors declare no conflict of interest.

Address correspondence and reprint requests to Stephanie Gaillard, MD, PhD, Department of Oncology, Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 201 North Broadway St, 10th floor, Baltimore, MD 21231. E-mail: stéphanie.gaillard@jhmi .edu.

王斐斐 翻译 梁莉 审校